Histopathological outcome of Leishmania major-infected BALB/c mice is improved by oral treatment with N-acetyl-l-cysteine
Open Access
- 1 March 2003
- journal article
- Published by Wiley in Immunology
- Vol. 108 (3), 401-408
- https://doi.org/10.1046/j.1365-2567.2003.01582.x
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- The polarization of Th1/Th2 balance is dependent on the intracellular thiol redox status of macrophages due to the distinctive cytokine productionInternational Immunology, 2002
- Regulation of the Interleukin (IL)-12R β2 Subunit Expression in Developing T Helper 1 (Th1) and Th2 CellsThe Journal of Experimental Medicine, 1997
- Heterogeneity of intracellular cytokine synthesis at the single-cell level in polarized T helper 1 and T helper 2 populations.The Journal of Experimental Medicine, 1995
- The Regulation of Immunity to Leishmania MajorAnnual Review of Immunology, 1995
- The Regulation of Immunity to Leishmania majorAnnual Review of Immunology, 1995
- Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania majorEuropean Journal of Immunology, 1994
- The presence of interleukin 4 during in vitro priming determines the lymphokine-producing potential of CD4+ T cells from T cell receptor transgenic mice.The Journal of Experimental Medicine, 1992
- HIV-induced cysteine deficiency and T-cell dysfunction — a rationale for treatment with N-acetylcysteineImmunology Today, 1992
- N-acetylcysteine as chemoprotectant in cancer chemotherapyThe Lancet, 1991
- Macrophage activation by interferon‐γ from host‐protective T cells is inhibited by interleukin (IL) 3 and IL 4 produced by disease‐promoting T cells in leishmaniasisEuropean Journal of Immunology, 1989